Department of Bioethics, Faculty of Medicine, Dalhousie University, Halifac, Canada.
Public Underst Sci. 2010 Jul;19(4):420-34. doi: 10.1177/0963662509104722.
The Canadian Act Respecting Assisted Human Reproduction and Related Research (AHR Act), which came into effect in 2004, was the culmination of fifteen years of policy development in this often controversial field. Drawing from a series of semi-structured elite interviews and extensive documentary research, we examine the path to policy for the AHR Act. We identified several influences on the Act's development, including: (1) feminist-informed activism which found a balance between rejecting the medical model of reproduction and instituting protections against the commodifying potential of reproductive technologies; (2) Canada's proximity to the United States (and its contrasting structures and stances); (3) the role of professional elites in supporting or resisting the proposed regulations; and (4) the tensions between federal and provincial jurisdiction in the Canadian federalist state. The path to this outcome provides an illuminating study of the tensions between internal and external pressures in the policy process.
《加拿大辅助人类生殖及相关研究法》（以下简称 AHR 法）于 2004 年生效，是该领域长达 15 年政策制定的成果。我们通过一系列半结构化的精英访谈和广泛的文献研究，考察了 AHR 法的政策制定路径。我们确定了影响该法案发展的几个因素，包括：（1）受女权主义启发的行动主义，它在拒绝生殖的医学模式和防止生殖技术的商品化之间找到了平衡；（2）加拿大与美国的接近（以及它们的对比结构和立场）；（3）专业精英在支持或抵制拟议法规方面的作用；（4）加拿大联邦制国家中联邦和省级管辖权之间的紧张关系。这一结果的出现过程为政策制定过程中内部和外部压力之间的紧张关系提供了一个有启发性的研究。
